project id: TCGA-UVM; case submitter id: TCGA-VD-A8KB; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 9.2; age at index: 66; days to birth: -24393; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1945; age at diagnosis: 24393; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1354.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 763; days to sample procurement: 0; initial weight: 20.0; sample id: 3106274b-1330-4c1d-9d6f-ee36138bc929; sample submitter id: TCGA-VD-A8KB-01A; portion id: fab67181-1e7b-46d1-8bb6-a23d9fb2c01f; portion submitter id: TCGA-VD-A8KB-01A-11; slide id: f581ff22-c343-4dff-8328-8f17927c72aa; slide submitter id: TCGA-VD-A8KB-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;